Vivos Therapeutics DNA oral device gets FDA nod for obstructive sleep apnea

Vivos Therapeutics has secured the US Food and Drug Administration (FDA) 510(k) clearance for its DNA oral device indicated for obstructive sleep apnea (OSA) treatment. ... Read More